HTA - NIHR131175
CLEAR: (CLozapine in EARly psychosis) A Multi-Centre, Randomised Controlled trial of Clozapine for Young People with Treatment Resistant Psychosis in Real World Settings
Project title: CLEAR: (CLozapine in EARly psychosis) A Multi-Centre, Randomised Controlled trial of Clozapine for Young People with Treatment Resistant Psychosis in Real World Settings
Call to action: 19/41 19/41 Clozapine for children and young people with treatment resistant schizophrenia
Research type: Primary Research
Chief investigator: Professor James MacCabe
Contractor: King's College London
Cost: £1,984,735.21
Co-investigators: Dr Charles Dixon, Dr Daniel Hayes, Dr Nicole Fung, Dr Rachel Elvins, Dr Richard Drake, Professor Helen Killaspy, Professor James Walters, Professor Jonathan Bisson, Professor Oliver Howes, Professor Paramala Santosh, Professor Philip McGuire, Professor Rachel Upthegrove, Professor Richard Emsley, Professor Sarah Byford.
Started: September 2021 | Status: Research in progress
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research